July 31, 2025
Physicians who see patients with syphilis should note that there is a voluntary recall of specific lots of Bicillin® L-A (Penicillin G Benzathine Injectable Suspension) by King Pharmaceuticals LLC., a subsidiary of Pfizer.
The recalled lots can be found at Pfizer: Bicillin Recall Letter. The Centers for Disease Control and Prevention (CDC) is not aware of any adverse events associated with this issue, and there is no indication at this time of reduced efficacy or need for retreatment.
Considering this recall and high levels of syphilis diagnoses in the United States (as detailed in the National Overview of STIs in 2023), CDC anticipates a limited supply of Bicillin L-A moving forward. Penicillin is the only recommended treatment for pregnant patients and babies with congenital syphilis. Given this information, the CDC recommends prioritizing Bicillin L-A for treating patients who are pregnant and for infants with congenital syphilis.
More information and full recommendations can be found on a resource created by the Minnestoa Department of Health - Bicillin L-A® Recall and Anticipated Shortage.
October 8, 2026
On September 29, a Hennepin County jury issued an $84 million malpractice verdict against Fairview Health Services, in a case involving a patient who died of complications following an exercise-induced heart attack.
October 8, 2026
A group of fifth-grade students from Lincoln Elementary School in St. Cloud got a firsthand look at the world of medicine on October 5, during a special Mini Medical School Day hosted by the University of Minnesota Medical School CentraCare Regional Campus St. Cloud.
October 8, 2026
On October 7, the MMA released an updated version of its “The One Big Beautiful Bill Act (OBBBA) Resource Guide for Physicians.”